Nigeria vs North Macedonia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Nigeria
62.0%
in 2025
North Macedonia
60.0%
in 2025
Nigeria rank
144th
North Macedonia rank
147th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Nigeria
- North Macedonia
How they compare
Nigeria currently reports 62.0% against 60.0% in North Macedonia, a difference of 2.0%.
The two have swapped places 5 times across 18 shared years of data; in 2008 it was North Macedonia ahead.
Nigeria ranks 144th and North Macedonia ranks 147th of 194 countries.
Nigeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nigeria | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 26.1% | 0.0% | 26.1% | Nigeria |
| 2020s | 58.5% | 54.5% | 4.0% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Nigeria or North Macedonia?
- Nigeria, at 62.0% against 60.0% in North Macedonia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Nigeria and North Macedonia?
- 2.0%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and North Macedonia?
- 18 years are reported by both, from 2008 to 2025.
- How do Nigeria and North Macedonia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Nigeria ranks 144th and North Macedonia ranks 147th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.